ArticleBioImpacts : BI2025
Recent advances and future prospects of metal organic frameworks (MOF)-based biosensors.
Article in BioImpacts : BI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Concept of 2D van der Waals Nanohybrids for Key Biomedical Applications.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a wide-ranging category of nanostructured materials, metal-organic-frameworks (MOFs) display distinctive characteristics, including uniformly ordered porosity, exceptional stability, and extensive tunability. These attributes enable the strategic design of MOFs in advanced biosensing platforms, including electrochemical and fluorescent biosensors. This editorial discusses the latest developments in MOF-based biosensors, emphasizing structural and surface functionalization strategies, enzyme immobilization, and signal amplification approaches that enhance analytical sensitivity and selectivity. Particular focus is placed on the MOF hybrid nanocomposites and micro/nano-sensing architectures designed to achieve precise control over activity-structure relationships. Moreover, current challenges in accomplishing scalable, biocompatible, and reproducible synthesis as well as in balancing stability with diffusion efficiency are examined. Finally, emerging trends combining computational modeling, advanced characterization, and machine-learning (ML)-guided design are highlighted as pathways toward next-generation analytical and point-of-care sensors with improved performance and broader practical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.